Inspire Medical Systems, Inc.
Financials
Valuation Metrics
Inspire Medical Systems, Inc.'s Market Cap is $1.94B. At end of 2025 it was $2.67B. Ranked #1976 of 3,118 in US market (top 63%), #1238 of 1,644 on NYSE (top 75%), #122 of 203 in Health Care Equipment & Services (top 60%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.94B | US#1,976/3,118 Sec#122/203 |
| Revenue | $899M | US#1,915/3,118 Sec#118/203 |
| Net Income | $135M | US#1,489/3,118 Sec#76/203 |
| Total Assets | $926M | US#2,503/3,118 Sec#133/203 |
| Net Assets | $826M | US#1,889/3,118 Sec#101/203 |
| Employees | 1,333 | US#1,876/3,118 Sec#125/203 |
| Value | ||
| P/E | 14.37x | US#723/3,118 Sec#11/203 |
| P/B | 2.35x | US#1,496/3,118 Sec#66/203 |
| PEG | 0.09x | US#196/3,118 Sec#6/203 |
| P/S | 2.16x | US#1,363/3,118 Sec#95/203 |
| EV/EBITDA | 22.17x | US#2,012/3,118 Sec#96/203 |
| FCF Yield | 6.03% | US#1,180/3,118 Sec#49/203 |
| Profitability | ||
| ROE | 16.36% | US#794/3,118 Sec#35/203 |
| ROA | 14.58% | US#246/3,118 Sec#13/203 |
| Op. Margin | 6.02% | US#1,877/3,118 Sec#102/203 |
| Revenue Growth | 4.35% | US#1,834/3,118 Sec#138/203 |
| Earnings Growth | 154.22% | US#192/3,118 Sec#10/203 |
| Financial Health | ||
| Debt Ratio | 12.16% | US#134/3,118 Sec#10/203 |
| Total Debt | $29M | US#2,686/3,118 Sec#164/203 |
| FCF | $117M | US#1,659/3,118 Sec#97/203 |
| Cash | $128M | US#2,047/3,118 Sec#127/203 |
| Current Ratio | 8.55x | US#295/3,118 Sec#21/203 |
| Net Debt/EBITDA | -1.19x | US#261/3,118 Sec#21/203 |
| Performance | ||
| 1Y Return | -6.56% | US#2,037/3,118 Sec#143/203 |
| 1M Return | -3.74% | US#1,956/3,118 Sec#148/203 |
| From 52W High | -54.19% | US#2,709/3,118 Sec#183/203 |
| 1Y MDD | -72.19% | US#2,960/3,118 Sec#192/203 |
| Trading | ||
| Volume | 802,654 shares | US#1,848/3,118 Sec#129/203 |
| Trading Value | $54M | US#1,385/3,118 Sec#102/203 |
| Per Share | ||
| EPS | $4.69 | US#727/3,118 Sec#41/203 |
| BPS | $28.65 | US#923/3,118 Sec#53/203 |
Company Info
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.